Why is Indrapr.Medical falling/rising?

As of 18-Jul, Indraprastha Medical Corporation Ltd is experiencing a price increase, with its current price at Rs 486.95, reflecting a rise of 2.55 (0.53%). Today's price summary indicates that the stock has outperformed its sector by 1.07% and has shown a trend reversal after three consecutive days of decline. The stock reached an intraday high of Rs 494.3, and there has been a notable increase in investor participation, with delivery volume rising by nearly 50% compared to the five-day average. Over the past month, the stock has gained 22.06%, significantly outperforming the Sensex, which only increased by 0.38%. Additionally, the company has demonstrated strong financial performance, with consistent positive results over the last 12 quarters, a high return on equity (ROE) of 19.57%, and a healthy operating profit growth rate of 30.21%.
In the broader market context, the stock's short-term performance has been favorable compared to the benchmark, as it has outperformed the Sensex over the past week, with a slight decline of 0.12% versus the benchmark's 0.90% drop. Despite a year-to-date decline of 6.88%, the stock's impressive one-year return of 101.22% and three-year return of 771.11% highlight its strong long-term growth potential. The stock is trading at a premium relative to its peers, supported by a low debt-to-equity ratio and a favorable PEG ratio of 0.9, indicating that it remains an attractive investment despite recent fluctuations.